Pinnacle Associates LTD Baxter International Inc Transaction History

Pinnacle Associates LTD

$6.3 Billion
Q3 2024

A detailed history of Pinnacle Associates LTD transactions in Baxter International Inc stock. As of the latest transaction made, Pinnacle Associates LTD holds 36,070 shares of BAX stock, worth $1.06 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

36,070

Previous 22,925 57.34%

Holding current value

$1.06 Million

Previous $766,000 78.72%

% of portfolio

0.02%

Previous 0.01%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	BUY	$32.85 - $40.26 $431,813 - $529,217	13,145 Added 57.34%	36,070 $1.37 Million
Q2 2024 Jul 30, 2024	SELL	$32.87 - $43.55 $410,973 - $544,505	-12,503 Reduced 35.29%	22,925 $766,000
Q1 2024 Apr 26, 2024	SELL	$37.88 - $43.77 $24,318 - $28,100	-642 Reduced 1.78%	35,428 $1.51 Million
Q4 2023 Jan 19, 2024	BUY	$31.71 - $38.95 $105,372 - $129,430	3,323 Added 10.15%	36,070 $1.39 Million
Q3 2023 Oct 23, 2023	SELL	$37.32 - $49.29 $150,399 - $198,638	-4,030 Reduced 10.96%	32,747 $1.24 Million
Q2 2023 Jul 26, 2023	BUY	$39.98 - $47.68 $36,221 - $43,198	906 Added 2.53%	36,777 $1.68 Million
Q1 2023 May 04, 2023	BUY	$37.58 - $52.57 $406,051 - $568,018	10,805 Added 43.11%	35,871 $1.45 Million
Q4 2022 Jan 31, 2023	SELL	$49.7 - $57.71 $116,496 - $135,272	-2,344 Reduced 8.55%	25,066 $1.28 Million
Q4 2022 Jan 25, 2023	BUY	$49.7 - $57.71 $131,357 - $152,527	2,643 Added 10.67%	27,410 $0
Q3 2022 Oct 31, 2022	SELL	$53.86 - $66.8 $3.71 Million - $4.6 Million	-68,880 Reduced 73.55%	24,767 $1.33 Million
Q2 2022 Aug 02, 2022	SELL	$63.83 - $80.0 $210,192 - $263,440	-3,293 Reduced 3.4%	93,647 $6.02 Million
Q1 2022 May 05, 2022	SELL	$76.85 - $89.45 $80,923 - $94,190	-1,053 Reduced 1.07%	96,940 $7.52 Million
Q4 2021 Feb 02, 2022	SELL	$74.57 - $87.19 $497,829 - $582,080	-6,676 Reduced 6.38%	97,993 $8.41 Million
Q3 2021 Oct 19, 2021	SELL	$73.77 - $83.61 $801,142 - $908,004	-10,860 Reduced 9.4%	104,669 $8.42 Million
Q2 2021 Aug 02, 2021	BUY	$80.5 - $88.01 $340,837 - $372,634	4,234 Added 3.8%	115,529 $9.3 Million
Q1 2021 May 12, 2021	BUY	$76.38 - $86.03 $56,521 - $63,662	740 Added 0.67%	111,295 $9.39 Million
Q4 2020 Jan 26, 2021	SELL	$75.39 - $82.36 $953,381 - $1.04 Million	-12,646 Reduced 10.26%	110,555 $8.87 Million
Q3 2020 Oct 23, 2020	SELL	$78.33 - $90.73 $601,887 - $697,169	-7,684 Reduced 5.87%	123,201 $9.91 Million
Q2 2020 Aug 14, 2020	SELL	$78.66 - $94.14 $77,165 - $92,351	-981 Reduced 0.74%	130,885 $11.3 Million
Q1 2020 May 13, 2020	BUY	$71.57 - $93.3 $495,335 - $645,729	6,921 Added 5.54%	131,866 $10.7 Million
Q4 2019 Feb 03, 2020	BUY	$76.7 - $88.45 $1.31 Million - $1.51 Million	17,092 Added 15.85%	124,945 $10.4 Million
Q3 2019 Nov 08, 2019	SELL	$81.4 - $89.78 $37,118 - $40,939	-456 Reduced 0.42%	107,853 $9.43 Million
Q2 2019 Aug 05, 2019	SELL	$73.44 - $82.41 $47,809 - $53,648	-651 Reduced 0.6%	108,309 $8.87 Million
Q1 2019 May 10, 2019	SELL	$64.48 - $81.31 $441,688 - $556,973	-6,850 Reduced 5.91%	108,960 $8.86 Million
Q4 2018 Feb 05, 2019	SELL	$61.45 - $77.8 $126,894 - $160,657	-2,065 Reduced 1.75%	115,810 $7.62 Million
Q3 2018 Nov 13, 2018	SELL	$70.71 - $77.75 $139,015 - $152,856	-1,966 Reduced 1.64%	117,875 $9.09 Million
Q2 2018 Aug 08, 2018	BUY	$63.43 - $75.41 $37,043 - $44,039	584 Added 0.49%	119,841 $8.85 Million
Q1 2018 May 11, 2018	SELL	$62.56 - $72.26 $2.28 Million - $2.63 Million	-36,435 Reduced 23.4%	119,257 $7.76 Million
Q4 2017 Feb 12, 2018	SELL	$61.45 - $66.05 $58,131 - $62,483	-946 Reduced 0.6%	155,692 $10.1 Million
Q3 2017 Nov 13, 2017	BUY	$59.5 - $64.61 $40,995 - $44,516	689 Added 0.44%	156,638 $9.83 Million
Q2 2017 Aug 09, 2017	BUY	N/A	155,949	155,949 $9.44 Million

Others Institutions Holding BAX

# of Institutions

1,007

Shares Held

450M

Call Options Held

2.79M

Put Options Held

2.44M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $14.9B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Associates LTD with notifications on news.

Account

Pinnacle Associates LTD Baxter International Inc Transaction History